<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report here a patient with relapsed follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> who developed secondary <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> 15 months after radioimmunotherapy (RIT) with (90)Y-ibritumomab tiuxetan, the fifth described case to date </plain></SENT>
<SENT sid="1" pm="."><plain>We review the literature for the potential causal relationship between RIT and secondary <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>/<z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> </plain></SENT>
</text></document>